IL233225A0 - Methods and formulations for the treatment of sialic acid deficiencies - Google Patents
Methods and formulations for the treatment of sialic acid deficienciesInfo
- Publication number
- IL233225A0 IL233225A0 IL233225A IL23322514A IL233225A0 IL 233225 A0 IL233225 A0 IL 233225A0 IL 233225 A IL233225 A IL 233225A IL 23322514 A IL23322514 A IL 23322514A IL 233225 A0 IL233225 A0 IL 233225A0
- Authority
- IL
- Israel
- Prior art keywords
- formulations
- methods
- sialic acid
- acid deficiencies
- treating sialic
- Prior art date
Links
- SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 title 1
- 230000007812 deficiency Effects 0.000 title 1
- 238000009472 formulation Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- SQVRNKJHWKZAKO-OQPLDHBCSA-N sialic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)OC1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-OQPLDHBCSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7012—Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261588069P | 2012-01-18 | 2012-01-18 | |
| US201261709549P | 2012-10-04 | 2012-10-04 | |
| PCT/US2013/022167 WO2013109906A2 (en) | 2012-01-18 | 2013-01-18 | Methods and formulations for treating sialic acid deficiencies |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL233225A0 true IL233225A0 (en) | 2014-08-31 |
Family
ID=48799814
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL233225A IL233225A0 (en) | 2012-01-18 | 2014-06-18 | Methods and formulations for the treatment of sialic acid deficiencies |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP2804600A4 (enExample) |
| JP (2) | JP2015504094A (enExample) |
| KR (1) | KR20150000872A (enExample) |
| CN (1) | CN104271125A (enExample) |
| AU (1) | AU2013209610B2 (enExample) |
| BR (1) | BR112014017587A8 (enExample) |
| CA (1) | CA2862836A1 (enExample) |
| IL (1) | IL233225A0 (enExample) |
| WO (1) | WO2013109906A2 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9241896B2 (en) | 2008-12-19 | 2016-01-26 | Ultragenyx Pharmaceutical Inc. | Methods and formulations for treating sialic acid deficiencies |
| US9511015B2 (en) | 2010-07-13 | 2016-12-06 | Ultragenyx Pharmaceutical Inc. | Methods and formulations for treating sialic acid deficiencies |
| BR112014009760B1 (pt) | 2011-10-24 | 2022-11-29 | Ultragenyx Pharmaceutical Inc | Análogos de ácido siálico, seu uso e composição farmacêutica |
| AR106025A1 (es) | 2015-09-14 | 2017-12-06 | Ultragenyx Pharmaceutical Inc | Formas cristalinas de ácido siálico o una sal o solvato de este |
| EP3486326A1 (en) | 2017-11-21 | 2019-05-22 | Jennewein Biotechnologie GmbH | Method for the purification of n-acetylneuraminic acid from a fermentation broth |
| CN117969774B (zh) * | 2024-04-02 | 2024-06-11 | 小仙炖霸州食品有限公司 | 一种自动化燕窝检测与分级系统 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2680842C (en) * | 2007-05-31 | 2015-11-24 | Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services National Institutes Of Health | N-acetyl mannosamine or derivatives thereof for use in treating a kidney disorder in a mammal |
| US20100159001A1 (en) * | 2008-12-19 | 2010-06-24 | Cardinal John R | Extended-Release Pharmaceutical Formulations |
| KR20120023064A (ko) * | 2009-05-15 | 2012-03-12 | 자이단호진 휴먼 사이언스 신코우자이단 | Ｇｎｅ 단백질의 기능 저하에 기인하는 질환의 치료용 의약제, 식품 조성물 및 식품 첨가물 |
| US9511015B2 (en) * | 2010-07-13 | 2016-12-06 | Ultragenyx Pharmaceutical Inc. | Methods and formulations for treating sialic acid deficiencies |
| BR112014009760B1 (pt) * | 2011-10-24 | 2022-11-29 | Ultragenyx Pharmaceutical Inc | Análogos de ácido siálico, seu uso e composição farmacêutica |
-
2013
- 2013-01-18 CA CA2862836A patent/CA2862836A1/en not_active Abandoned
- 2013-01-18 JP JP2014553457A patent/JP2015504094A/ja active Pending
- 2013-01-18 BR BR112014017587A patent/BR112014017587A8/pt not_active Application Discontinuation
- 2013-01-18 WO PCT/US2013/022167 patent/WO2013109906A2/en not_active Ceased
- 2013-01-18 AU AU2013209610A patent/AU2013209610B2/en not_active Expired - Fee Related
- 2013-01-18 EP EP13739040.7A patent/EP2804600A4/en not_active Withdrawn
- 2013-01-18 CN CN201380015020.XA patent/CN104271125A/zh active Pending
- 2013-01-18 KR KR1020147022912A patent/KR20150000872A/ko not_active Withdrawn
-
2014
- 2014-06-18 IL IL233225A patent/IL233225A0/en unknown
-
2017
- 2017-07-21 JP JP2017141883A patent/JP2017186381A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2013209610A1 (en) | 2014-07-10 |
| EP2804600A2 (en) | 2014-11-26 |
| CA2862836A1 (en) | 2013-07-25 |
| CN104271125A (zh) | 2015-01-07 |
| WO2013109906A2 (en) | 2013-07-25 |
| KR20150000872A (ko) | 2015-01-05 |
| JP2015504094A (ja) | 2015-02-05 |
| AU2013209610B2 (en) | 2017-11-30 |
| BR112014017587A2 (pt) | 2017-06-13 |
| EP2804600A4 (en) | 2015-09-02 |
| BR112014017587A8 (pt) | 2017-07-04 |
| JP2017186381A (ja) | 2017-10-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL235826A (en) | Diazaspirocycloalkanes and thenaspirocycloalkanes and their preparation | |
| IL238416A0 (en) | Preparations and methods for the treatment of diseases caused by protein pathology | |
| DK3292875T3 (en) | Compositions and methods for treating diseases | |
| EP2593109A4 (en) | METHOD AND FORMULATIONS FOR THE TREATMENT OF SIALIC ACID DEFICIENCIES | |
| IL235062A0 (en) | Compounds and methods for antiviral therapy | |
| ZA201404676B (en) | Compositions and methods for treating metabolic disorders | |
| PL2882779T3 (pl) | Pochodna kwasu hialuronowego, sposób jej wytwarzania, sposób jej modyfikacji i jej zastosowanie | |
| IL234829A0 (en) | Methods and preparations for treating inflammation | |
| IL235709A0 (en) | A process for isolation/purification of cells and methods for its use | |
| SG11201408326TA (en) | Preparation method for perfluoro-2-methyl-3-pentanone and intermediate | |
| IL233225A0 (en) | Methods and formulations for the treatment of sialic acid deficiencies | |
| IL235805A (en) | Pyrimidinyl-Diazaspiro compound and process for preparation | |
| LT2931696T (lt) | Nepertraukiamas (s)-2-acetiloksipropiono rūgšties gamybos būdas | |
| GB201201062D0 (en) | Radiofluorination method | |
| PL2882432T3 (pl) | Sposób leczenia trądziku | |
| EP2813577A4 (en) | METHOD OF SUPPRESSING THE EFFECTS OF ASCORBIC ACID | |
| ZA201407214B (en) | Therapeutic preparation and process for preparing said therapeutic preparation | |
| GB201222736D0 (en) | Composition and process | |
| GB201100455D0 (en) | Methods relating to treatment | |
| IL213610A0 (en) | Composition for treating dermatological conditions | |
| GB201205449D0 (en) | Treatment process | |
| GB201217173D0 (en) | Therapeutic method | |
| PL395177A1 (pl) | Nowe karboamidowe pochodne dekstrometorfanu i sposób ich wytwarzania |